
A novel biomarker-based scoring system effectively differentiates MINOCA from MICAD, surpassing individual biomarkers. The combined index demonstrated superior accuracy (AUC: 0.918). Elevated IL-6 and troponin T were strongly associated with MICAD risk (OR: 1.58 and OR: 2.27, respectively). The system predicts the diagnosis with a six-fold increase in MICAD risk for each one-point increase in the index (OR: 6.16), offering improved diagnostic capability before angiography.
Like
Save
Share